Stem Cell Cancer


Cancer When transplanted into an animal host, stem cells (CSCs), a tiny fraction of cells within tumours, are capable of self-renewal, differentiation, and tumorigenicity. To recognise and enrich CSCs, a range of cell surface markers, including CD44, CD24, and CD133, are frequently utilised.

Some cancers, such as leukaemia, lymphoma, and myeloma, can be treated by bone marrow or stem cell transplantation. High dose chemotherapy and occasionally radiotherapy are used to treat them. They may also be referred to as intense treatment, stem cell rescue, or bone marrow rescue. At 20 years after transplantation, the study cohort's estimated survival rate was 80.4% (95% CI, 78.1% to 82.6%). Age at transplantation was inversely linked with survival after five years.


 


  • Chemotherapy
  • Radiotherapy

Related Conference of Stem Cell Cancer

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Stem Cell Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in